How does MDDiabeticPro differ from other diabetes tests?
PMLS offers a variety of biomarkers on our diabetes test panel. Besides running a normal A1C test, PMLS goes further and tests a patient’s Fasting Glucose, GlycoMark, Adiponectin, Leptin, HOMA-IR, Insulin, and C-peptide, but we don’t stop there. To give patient’s a look at the bigger picture, we also run a Comorbidity Assessment of Cardiovascular and Renal biomarkers, as well as a Genetic Predisposition called DIABETESpredict™. With DIABETESpredict™, doctors can help their patients know their risk for type 2 diabetes earlier.
Know your risk with DIABETESPredit™
DIABETESpredict™ is a genotyping tool for type 2 diabetes risk assessment. It analyzes the main genetic variants associated with T2D, taking into account multi-ethnic associations. DIABETESpredict™ identifies high risk individuals and gives them additional information to implement lifestyle changes. Early identification of type 2 diabetes enables prevention and with DIABETESpredict™ doctors are empowered to help their patients further.
We want to hear from you! Tell us more about your interest in MDDiabeticPro today.
Read Our Blog
November is National Diabetes Month in the US, and over the last year and a half, people with diabetes have faced heightened risks to their health, as their illness makes them more vulnerable to the worst effects of COVID-19. According to the latest research, the...
Labs Like Premier Medical Laboratory Services Now Seeing Increased Demand for Various Molecular Diagnostic Tests
~As social distancing measures have decreased, demand for medical tests other than COVID-19 increase~ GREENVILLE, SC September 23, 2020 – At the onset of the pandemic the nation began to practice social distancing, and subsequently, many stopped scheduling visits...